Synta Pharmaceuticals Corp. · Lexington, MA United States (NASDAQ: SNTA)
| 45 Hartwell Ave. | Phone: 781-274-8200 |
| Lexington, MA | Fax: 781-274-8228 |
| 02421 | |
| United States | 
Map This Company |
Synta Pharmaceuticals Corp. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Synta Pharmaceuticals doesn't fill stockings, but it might eventually fill the medical need of treating cancer. The drug development company has a handful of candidates in clinical and pre-clinical development stages. Its ganetespib and elesclomol compounds are in clinical trials as possible treatments for several types of cancer, including non-small cell lung cancer (NSCLC) and colorectal, pancreatic, ovarian, and breast cancers. Synta's preclinical research efforts include potential therapies for autoimmune diseases, inflammatory conditions, and cancerous tumors.
Synta Pharmaceuticals Corp. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: SNTA Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 112 |
Executives
30 executives listed for Synta Pharmaceuticals Corp.'s Lexington, MA location.
| Chairman | Keith Gollust | |
|---|---|---|
| Managing Director | Heather Storm | |
| President, CEO, and Director | Safi Bahcall |